StockClub

ANTH

ANTHAnthera Pharmaceuticals, Inc.$ --
Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc.

ANTH

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2018FY2018 Q1
Revenue
0M USD
YoY -
Operating Income
-11M USD
YoY -3.5%
Net Income
-4M USD
YoY +62.1%
EPS
-0.2$
YoY +88.4%

Revenue

$0
FY2016 Q2$145,000
$145,000
Q2
FY2016 Q3$145,000
$145,000
Q3
FY2016 Q4$145,000
$145,000
Q4
FY2017 Q1$0
$0
Q1
FY2017 Q2$0
$0
Q2
FY2017 Q3$0
$0
Q3
FY2017 Q4$0
$0
Q4
FY2018 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-4.4M
FY2016 Q2$-26.1M
$-26.1M
Q2
FY2016 Q3$-42.5M
$-42.5M
Q3
FY2016 Q4$-55.5M
$-55.5M
Q4
FY2017 Q1$-11.7M
$-11.7M
Q1
FY2017 Q2$-2.4M
$-2.4M
Q2
FY2017 Q3$-7.1M
$-7.1M
Q3
FY2017 Q4$-17.1M
$-17.1M
Q4
FY2018 Q1$-4.4M
$-4.4M
Q1
Actual
+$7.3M (+62.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2012
Actual:$0
FY2012
$0
FY2013
Actual:$0
FY2013
$0
FY2014
Actual:$0
FY2014
$0
FY2015BEAT
Actual:$3.2M
Est:$1.4M
FY2015BEAT
$3.2M
FY2016BEAT
Actual:$145,000
Est:$122,500
FY2016BEAT
$145,000
FY2017IN-LINE
Actual:$0
Est:$0
FY2017IN-LINE
$0

Analyst Estimates